Market Research Logo

Global Sickle Cell Market- Industry Analysis & Outlook (2020-2030)

Global Sickle Cell Market- Industry Analysis & Outlook (2020-2030)

Sickle Cell (SC) is a genetic blood disorder caused by inheriting abnormal hemoglobin (Hb) genes from parents. Normally, red blood cells (RBC) have disc-like shapes which help them to travel throughout the blood vessels. But in the case of SC, red blood cells of a person’s blood take an abnormal sickle-like shape. Due to SC, red blood cells become sticky and inelastic. These RBCs block the blood circulation in different parts of body by getting blocked in the small blood vessels. Red blood cells live for about 120 days but these sickle cells live for only 10-20 days. There are various types of sickle cell disorders caused by different mutations in hemoglobin genes. Although, all types of sickle cell disorder have similar symptoms but they differ in their severity and nature of occurrence.

Currently, sickle cell is affecting approximately 20 to 25 million people worldwide and approximately 300 thousand births occur with sickle cell annually. Sickle cell has a high concentration rate in malaria endemic parts of worlds, especially, African, Middle Eastern and South Asian regions. In many African countries, 10% to 40% population carries sickle cell traits.

The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.

The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.

The report “Global Sickle Cell Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S, and Europe along with the global market. The report profiles key players of the market including Novartis, Bristol-Myers Squibb, Shire Plc, Bluebird Bio and Global Blood Therapeutics Inc.


1. Overview
1.1 Sickle Cell
Table 1: Sickle Cell Prevalence
1.2 Types of Sickle Cell
Table 2: Types of Sickle Cell
1.3 Symptoms & Diagnosis
1.4 Treatment
Table 3: Sickle Cell Treatments
2. Global Market
2.1 Global Sickle Cell Drug Market Forecast by Value
Table 4: Global Sickle Cell Drug Market Forecast by Value (2020-2030)
2.2 Sickle Cell Drug Market by Region
Table 5: Global Sickle Cell Drug Market by Region (2020/2025/2030)
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Sickle Cell Drug Market Forecast by Value
Table 6: The U.S. Sickle Cell Drug Market Forecast by Value (2020-2030)
3.1.2 The U.S. Sickle Cell Patient Volume Forecast
Table 7: The U.S. Sickle Cell Patient Volume Forecast (2020-2030)
3.1.3 The U.S. Sickle Cell Treated Patient Volume Forecast
Table 8: The U.S. Sickle Cell Treated Patient Volume Forecast (2020-2030)
3.1.4 The U.S. Sickle Cell Market Forecast by Treatment Cost
Table 9: The U.S. Sickle Cell Market Forecast by Treatment Cost (2020-2030)
3.2 Europe
3.2.1 Europe Sickle Cell Drug Market Forecast by Value
Table 10: Europe Sickle Cell Drug Market Forecast by Value (2021-2030)
3.2.2 Europe Sickle Cell Patient Volume Forecast
Table 11: Europe Sickle Cell Patient Volume Forecast (2021-2030)
3.2.3 Europe Sickle Cell Treated Patient Volume Forecast
Table 12: Europe Sickle Cell Treated Patient Volume Forecast (2021-2030)
3.2.4 Europe Sickle Cell Market Forecast by Treatment Cost
Table 13: Europe Sickle Cell Market Forecast by Treatment Cost (2021-2030)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising American-African Population
Table 14: African-American Population (2012-2016)
4.1.2 Rising Economic Growth
Table 15: Global GDP per Capita (2012-2016)
4.1.3 Increasing Healthcare Expenditure
Table 16: Global Healthcare Expenditure (2012-2016)
4.1.4 Increasing Prevalence of Sickle Cell
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
Table 17: Drugs in Development (2016)
4.2.2 Rising Research Grants
4.3 Challenges
4.3.1 Regulatory Challenges
4.3.2 Associated Risks
4.3.3 Slow Adoption of Treatment
5. Competition
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
Table 18: Revenue Comparison of Key Players (2016)
5.1.2 Market Cap Comparison of Key Players (2016)
Table 19: Market Cap Comparison of Key Players (2016)
6. Company Profiles
6.1 Novartis
6.1.1 Business Overview
Table 20: Novartis Net Sales by Segment (2016)
Table 21: Novartis Net Sales by Region (2016)
6.1.2 Financial Overview
Table 22: Novartis Net Sales and Net Income (2012-2016)
6.1.3 Business Strategies
Table 23: Novartis R&D Expenditure (2014-2016)
6.2 Bristol-Myers Squibb
6.2.1 Business Overview
Table 24: Bristol-Myers Squibb Revenue by Segment (2016)
Table 25: Bristol-Myers Squibb Revenue by Region (2016)
6.2.2 Financial Overview
Table 26: Bristol-Myers Squibb Revenue and Net Earnings (2012-2016)
6.2.3 Business Strategies
Table 27: Bristol-Myers Squibb R&D Expenditure (2014-2016)
6.3 Shire Plc.
6.3.1 Business Overview
Table 28: Shire’s Revenue by Product Segment (2016)
6.3.2 Financial Overview
Table 29: Shire Plc. Revenue and Net Income (2012-2016)
6.3.3 Business Strategies
Table 30: Shire Plc. R&D Expenditure (2014-2016)
6.4 Bluebird Bio
6.4.1 Business Overview
Table 31: Bluebird Bio’s Product Pipeline
6.4.2 Financial Overview
Table 32: Bluebird Bio Revenue and Net Loss (2012-2016)
6.4.3 Business Strategies
Table 33: Bluebird Bio R&D Expenditure (2014-2016)
6.5 Global Blood Therapeutics Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
Table 34: Global Blood Therapeutics Inc. Net Loss (2013-2016)
6.5.3 Business Strategies
Table 35: Global Blood Therapeutics Inc. R&D Expenditure (2014-2016)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report